[ACRS] QoQ Quarter Result on 31-Dec-2022 [#Q4]

Stock
[ACRS] Aclaris Therapeutics, Inc.
Announcement Date
23-Feb-2023
Financial Year
2022
Quarter
31-Dec-2022 [#Q4]
Profit Trend
QoQ- -56.81%
YoY- -45.99%
Quarter Report
ACRS's Result
ACRS's Financial Summary
View:
Show?
Quarter Result
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
Revenue 9,282 1,869 2,528 7,753 19,018 1,528 1,453 243.89%
PBT -29,261 -29,569 -28,160 -27,635 -19,952 -20,532 -18,789 34.31%
Tax -219 -1,500 -1,758 5,656 1,278 -3,862 -1,318 -69.74%
NP -29,261 -29,569 -26,402 -33,291 -21,230 -16,670 -17,471 40.98%
Tax Rate - - - - - - - -
Total Cost 38,543 31,438 28,930 41,044 40,248 18,198 18,924 60.60%
Ratio Analysis
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
NP Margin -315.24 -1,582.08 -1,044.38 -429.40 -111.63 -1,090.97 -1,202.41 -59.00%
Per Share
30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 31/03/22 CAGR
EPS -0.41 -0.42 -0.39 -0.50 -0.32 -0.25 -0.28 28.91%
EPS Diluted -0.41 -0.42 -0.39 -0.50 -0.32 -0.25 -0.28 28.91%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.